Glutathione catabolism as a signaling mechanism
Section snippets
GSH, GGT and iron reduction
γ-Glutamyl transpeptidase (E.C. 2.3.2.2) is normally found in serum, and is expressed by a wide range of normal cell types [1], [2] as well as in a number of neoplastic cell lines [3] and human spontaneous tumors (reviewed in [4]). GGT catalyzes the first step in the degradation of extracellular GSH, i.e. the hydrolysis of the γ-glutamyl bond between glutamate and cysteine [5]. In so doing GGT releases cysteinyl-glycine, which is subsequently cleaved to cysteine and glycine by plasma membrane
GSH/GGT-dependent prooxidants and the redox status of protein thiols
By cleaving the γ-glutamyl bond in GSH, GGT provides the first step in catabolism of extracellular GSH. With the contribution of membrane dipeptidase activities, precursor aminoacids glycine and cysteine are then released, which can cross the plasma membrane and are re-utilized for intracellular GSH synthesis [14]. Since it has been documented that a continuous efflux of GSH occurs from a number of cell types through specific out-transporters [15], it is conceivable that a major function of GGT
Effects on the cellular proliferation/apoptosis balance
It is widely recognized that prooxidants can play a modulatory role on the transduction of proliferative/apoptotic signals, due to their ability to interact with redox-sensitive regions of growth factor receptors, protein kinases and transcription factors [24], [25], [26]. A first indication that prooxidant reactions originating from GSH catabolism could play a role in these processes came from studies with human A2780 ovarian cancer cells, showing that exogenous GSH exerts an antiproliferative
Molecular targets in the signal transduction chains
The described effects on the proliferative/apoptotic balance of cells imply the interaction of GSH/GGT-mediated prooxidants with critical targets in the intracellular signal transduction cascade, of which PARP is a first example. Among several redox-sensitive targets, the transcription factor NF-κB is perhaps the best known and studied [29]. Studies were thus aimed to verify the likely involvement of NF-κB in redox changes consequent to GSH catabolism. Using murine V79-GGT cells, highly
Concluding remarks
The experimental evidence obtained in our and other laboratories allows to describe a novel aspect of glutathione metabolism, i.e. the redox changes consequent to its cleavage by GGT. With the mediation of iron—and conceivably of other transition metals as well—GSH catabolism leads to the generation of ROS and thiyl radicals, whose prooxidant action is detectable on protein thiol groups in the first place (Fig. 5, Fig. 6). Such processes appear to involve a variety of cellular targets,
Acknowledgements
The authors are indebted to the Associazione Italiana Ricerca sul Cancro (AIRC, Milan, Italy) for its generous financial support to the research presented in this report.
References (38)
- et al.
Redox modulation of cell surface protein thiols in U937 lymphoma cells: the role of γ-glutamyl transpeptidase-dependent H2O2 production and S-thiolation
Free Radic. Biol. Med.
(1999) - et al.
Thiol-dependent lipid peroxidation
Biochem. Biophys. Res. Commun.
(1982) - et al.
Thiol-mediated NTA–Fe(III) reduction and lipid peroxidation
Arch. Biochem. Biophys.
(1994) - et al.
Effect of pH on mutagenesis by thiols in Salmonella typhimurium TA102
Mutat. Res.
(1989) - et al.
Gamma-glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells
Free Radic. Biol. Med.
(1997) - et al.
γ-Glutamyl transpeptidase from kidney
Methods Enzymol.
(1985) - et al.
Role of metals in oxygen radical reactions
Free Radic. Biol. Med.
(1985) - et al.
Gamma-glutamyltransferase-dependent generation of reactive oxygen species from a glutathione/transferrin system
Free Radic. Biol. Med.
(1998) - et al.
Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways
Free Radic. Biol. Med.
(1996) Redox signaling and the emerging therapeutic potential of thiol antioxidants
Biochem. Pharmacol.
(1998)